Full-text resources of PSJD and other databases are now available in the new Library of Science.
Visit https://bibliotekanauki.pl


Preferences help
enabled [disable] Abstract
Number of results
2014 | 12 | 1 | 49-56

Article title

Rekomendacje Polskiego Towarzystwa Ginekologii Onkologicznej dotyczące nabłonkowych nowotworów jajnika: raka jajnika oraz guzów o granicznej złośliwości w ciąży


Title variants

Recommendations of the Polish Gynecological Oncology Society concerning epithelial tumors of the ovary: ovarian cancer and borderline tumors in pregnancy

Languages of publication












Physical description


  • Klinika Perinatologii i Chorób Kobiecych Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu. Kierownik: prof. dr hab. n. med. Krzysztof Drews. Dr hab. n. med. Anna Markowska, Klinika Perinatologii i Chorób Kobiecych Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu, ul. Polna 33, 60-535 Poznań, tel.: +48 61 841 92 73
  • Klinika Ginekologii Operacyjnej Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu. Kierownik: prof. dr hab. n. med. Stefan Sajdak, ul. Polna 33, 60-535 Poznań, tel.: +48 61 841 92 73
  • Oddział Ginekologii Onkologicznej, Katedra i Klinika Onkologii Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu. Kierownik: prof. dr hab. n. med. Mieczysław Komarnicki. Prof. dr hab. n. med. Janina Markowska, Oddział Ginekologii Onkologicznej, Katedra i Klinika Onkologii Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu, ul. Szamarzewskiego 82/84, 60-569 Poznań, tel.: +48 61 854 90 14


  • 1. Hoover K., Jenkins T.R.: Evaluation and management of adnexal mass in pregnancy. Am. J. Obstet. Gynecol. 2011; 205: 97–102.
  • 2. Giuntoli R.L. 2nd, Vang R.S., Bristow R.E.: Evaluation and management of adnexal masses during pregnancy. Clin. Obstet. Gynecol. 2006; 49: 492–505.
  • 3. Aggarwal P., Kehoe S.: Ovarian tumours in pregnancy: a literature review. Eur. J. Obstet. Gynecol. Reprod. Biol. 2011; 155: 119–124.
  • 4. Marret H., Lhommé C., Lecuru F. i wsp.: Guidelines for the management of ovarian cancer during pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol. 2010; 149: 18–21.
  • 5. Kondi-Pafiti A., Grigoriadis C., Iavazzo C. i wsp.: Clinicopathological characteristics of adnexal lesions diagnosed during pregnancy or cesarean section. Clin. Exp. Obstet. Gynecol. 2012; 39: 458–461.
  • 6. Oehler M.K., Wain G.V., Brand A.: Gynaecological malignancies in pregnancy: a review. Aust. N. Z. J. Obstet. Gynaecol. 2003; 43: 414–420.
  • 7. Pavlidis N.A.: Coexistence of pregnancy and malignancy. Oncologist 2002; 7: 279–287.
  • 8. Mogos M.F., Rahman S., Salihu H.M. i wsp.: Association between reproductive cancer and fetal outcomes: a systematic review. Int. J. Gynecol. Cancer 2013; 23: 1171–1177.
  • 9. Yacobozzi M., Nguyen D., Rakita D.: Adnexal masses in pregnancy. Semin. Ultrasound CT MR 2012; 33: 55–64.
  • 10. Hill L.M., Martin J.G., Deutsch K. i wsp.: Sonographic visualization of the ovaries throughout pregnancy. Obstet. Gynecol. 1996; 88: 830–832.
  • 11. Minig L., Otaño L., Diaz-Padilla I. i wsp.: Therapeutic management of epithelial ovarian cancer during pregnancy. Clin. Transl. Oncol. 2013; 15: 259–264.
  • 12. Lerner J.P., Timor-Tritsch I.E., Federman A., Abramovich G.: Transvaginal ultrasonographic characterization of ovarian masses with an improved, weighted scoring system. A m. J. Obstet. Gynecol. 1994; 170: 81–85.
  • 13. Granberg S., Wikland M., Jansson I.: Macroscopic characterization of ovarian tumors and the relation to the histological diagnosis: criteria to be used for ultrasound evaluation. Gynecol. Oncol. 1989; 35: 139–144.
  • 14. American College of Obstetricians and Gynecologists Committee on Obstetric Practice: ACOG Committee Opinion. Number 299. Guidelines for diagnostic imaging during pregnancy. Obstet. Gynecol. 2004; 104: 647–651.
  • 15. Stuart G.C., Kitchener H., Bacon M. i wsp.; participants of 4th Ovarian Cancer Consensus Conference; Gynecologic Cancer InterGroup: 2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus Conference. Int. J. Gynecol. Cancer 2011; 21: 750–755.
  • 16. Oduncu F.S., Kimmig R., Hepp H., Emmerich B.: Cancer in pregnancy: maternal-fetal conflict. J. Cancer Res. Clin. Oncol. 2003; 129: 133–146.
  • 17. Amant F., Van Calsteren K., Halaska M.J. i wsp.: Gynecologic cancers in pregnancy: guidelines of an international consensus meeting. Int. J. Gynecol. Cancer 2009; 19 supl. 1: S1–S12.
  • 18. Morice P., Uzan C., Gouy S. i wsp.: Gynaecological cancers in pregnancy. Lancet 2012; 379: 558–569.
  • 19. Cardonick E., Usmani A., Ghaffar S.: Perinatal outcomes of a pregnancy complicated by cancer, including neonatal follow-up after in utero exposure to chemotherapy: results of an international registry. Am. J. Clin. Oncol. 2010; 33: 221–228.
  • 20. Satoh T., Hatae M., Watanabe Y. i wsp.: Outcomes of fertility- sparing surgery for stage I epithelial ovarian cancer: a proposal for patient selection. J. Clin. Oncol. 2010; 28: 1727–1732.
  • 21. Brewer M., Kueck A., Runowicz C.D.: Chemotherapy in pregnancy. Clin. Obstet. Gynecol. 2011; 54: 602–618.
  • 22. Tropé C., Kaern J.: Adjuvant chemotherapy for early-stage ovarian cancer: review of the literature. J. Clin. Oncol. 2007; 25: 2909–2920.
  • 23. Friedman J.D., Ramsey P.S., Ramin K.D. i wsp.: Pneumoamnion and pregnancy loss after second-trimester laparoscopic surgery. Obstet. Gynecol. 2002; 99: 512–513.
  • 24. Zemlickis D., Lishner M., Degendorfer P. i wsp.: Fetal outcome after in utero exposure to cancer chemotherapy. Arch. Intern. Med. 1992; 152: 573–576.
  • 25. Zagouri F., Sergentanis T.N., Chrysikos D. i wsp.: Taxanes for ovarian cancer during pregnancy: a systematic review. Oncology 2012; 83: 234–238.
  • 26. Gambino A., Gorio A., Carrara L. i wsp.: Cancer in pregnancy: maternal and fetal implications on decision-making. Eur. J. Gynaecol. Oncol. 2011; 32: 40–45.
  • 27. Cardonik E., Bhat A., Gilmandyar D., Somer R.: Maternal and fetal outcomes of taxane chemotherapy in breast and ovarian cancer during pregnancy: case series and review of the literature. Ann. Oncol. 2012; 23: 3016–3023.
  • 28. Abdel-Hady el-S., Hemida R.A., Gamal A. i wsp.: Cancer during pregnancy: perinatal outcome after in utero exposure to chemotherapy. Arch. Gynecol. Obstet. 2012; 286: 283–286.
  • 29. St-Pierre M.V., Serrano M.A., Macias R.I. i wsp.: Expression of members of the multidrug resistance protein family in human term placenta. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000; 279: R1495–R1503.
  • 30. du Bois A., Quinn M., Thigpen T. i wsp.: 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004). Ann. Oncol. 2005; 16 supl. 8: viii7–viii12.
  • 31. Smith E.R., Borowsky M.E., Jain V.D.: Intraperitoneal chemotherapy in a pregnant woman with ovarian cancer. Obstet. Gynecol. 2013; 122: 481–483.

Document Type


Publication order reference


YADDA identifier

JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.